Jefferies Group’s Immunogen Inc IMGN Stock Holding History

Jefferies Group’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-15,000	Closed	-$85K	–	2086
2021 Q3	$85K	Hold	15,000	–	–	﹤0.01%	1563
2021 Q2	$98.8K	Buy	+15,000	New	+$105K	﹤0.01%	1489
2019 Q2	–	Sell	-43,800	Closed	-$119K	–	2943
2019 Q1	$119K	Buy	+43,800	New	+$190K	﹤0.01%	2076
2018 Q4	–	Sell	-35,000	Closed	-$331K	–	2683
2018 Q3	$331K	Sell	35,000 -18,900	-35%	-$182K	﹤0.01%	1828
2018 Q2	$524K	Buy	+53,900	New	+$568K	﹤0.01%	1565
2015 Q2	–	Sell	-71,200	Closed	-$637K	–	3545
2015 Q1	$637K	Sell	71,200 -3,300	-4%	-$23.9K	﹤0.01%	1272
2014 Q4	$454K	Buy	+74,500	New	+$681K	﹤0.01%	1328
2014 Q3	–	Sell	-50,000	Closed	-$593K	–	2519
2014 Q2	$593K	Buy	+50,000	New	+$628K	0.01%	1141

Other funds holding IMGN

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jefferies Group's IMGN Position: Q4 2021 in Review

Jefferies Group sold out of Immunogen Inc (IMGN) in Q4 2021, closing a stake of 200,340 shares — an estimated $1.14M sold.

Jefferies Group first reported a position in IMGN in Q3 2013 and held it in 7 quarters. The position peaked at $1.14M in Q3 2021. 236 funds tracked by Wall St. Rank hold IMGN as of Q4 2021.

Jefferies Group reported no remaining Immunogen Inc position as of Q4 2021 after selling out during the quarter.
Jefferies Group sold 200,340 Immunogen Inc shares in Q4 2021, an estimated $1.14M.
Jefferies Group first reported a position in Immunogen Inc in Q3 2013 and held it in 7 quarters.
Jefferies Group's Immunogen Inc position peaked at $1.14M in Q3 2021.
236 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2021.

Based on Jefferies Group's 13F filing for Q4 2021, filed 14 Feb 2022.